Improvement in Growth After 1 Year of Growth Hormone Therapy in Well-Nourished Infants with Growth Retardation Secondary to Chronic Renal Failure
Open Access
- 1 July 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 5 (7), 1190-1197
- https://doi.org/10.2215/cjn.07791109
Abstract
Background and objectives: Our aim was to evaluate the growth-promoting effect of growth hormone (GH) treatment in infants with chronic renal failure (CRF) and persistent growth retardation despite adequate nutritional and metabolic management. Design, setting, participants, & measurements: The study design included randomized, parallel groups in an open, multicenter trial comparing GH (0.33 mg/kg per wk) with nontreatment with GH during 12 months. Sixteen infants who had growth retardation, were aged 12 ± 3 months, had CRF (GFR ≤60 ml/min per 1.73 m2), and had adequate nutritional intake and good metabolic control were recruited from eight pediatric nephrology departments from Spain and Portugal. Main outcome measures were body length, body weight, bone age, biochemical and hormonal analyses, renal function, bone mass, and adverse effects. Results: Length gain in infants who were treated with GH was statistically greater (P < 0.05) than that of nontreated children (14.5 versus 9.5 cm/yr; SD score 1.43 versus −0.11). The GH-induced stimulation of growth was associated with no undesirable effects on bone maturation, renal failure progression, or metabolic control. In addition, GH treatment improved forearm bone mass and increased serum concentrations of total and free IGF-I and IGF-binding protein 3 (IGFBP-3), whereas IGF-II, IGFBP-1, IGFBP-2, GH-binding protein, ghrelin, and leptin were not modified. Conclusions: Infants with CRF and growth retardation despite good metabolic and nutritional control benefit from GH treatment without adverse effects during 12 months of therapy.Keywords
This publication has 39 references indexed in Scilit:
- Nutrition in children with CRF and on dialysisPediatric Nephrology, 2007
- Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statementPediatric Nephrology, 2006
- Growth hormone/insulin-like growth factor system in children with chronic renal failurePediatric Nephrology, 2005
- Effect of renal failure and dialysis on circulating ghrelin concentration in childrenNephrology Dialysis Transplantation, 2004
- Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed childrenPediatric Nephrology, 2003
- Serum leptin and IGF-I during growth hormone treatment in chronic renal failurePediatric Nephrology, 2002
- Bone density and body composition in chronic renal failure: effects of growth hormone treatmentPediatric Nephrology, 2000
- Long-term enteral nutrition in infants and young children with chronic renal failurePediatric Nephrology, 1999
- Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosaThe Journal of Pediatrics, 1997
- Multiple Endocrine Abnormalities of the Growth Hormone and Insulin-Like Growth Factor Axis in Prepubertal Children with Exogenous Obesity: Effect of Short- and Long-Term Weight ReductionJournal of Clinical Endocrinology & Metabolism, 1997